PERRY A KARSEN
CIK 1260573 · see remarks · last filed 2023-07-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$318.9K
Companies
7
Total Filings
65
Lifetime Open-Market Net
-$37.29M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LENZ Therapeutics, Inc. (GRPH) Delisted | Director | 164,034 | $22.26 | $3.65M | $0 | 3 | 2023-07-21 |
| Jounce Therapeutics, Inc. (JNCE) Delisted | Director | 0 | $1.88 | $0 | $80.0K | 8 | 2023-05-04 |
| NTLA | Director | 26,336 | $12.11 | $318.9K | -$4.75M | 7 | 2020-12-18 |
| VYGR | Director | — | $3.50 | — | $0 | 4 | 2019-06-17 |
| CELGENE CORP /DE/ (CELGZ) Delisted | see remarks | 68,071 | — | — | -$32.62M | 30 | 2015-12-18 |
| NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Director | 37,528 | $0.00 | $4 | $0 | 5 | 2015-07-21 |
| AGIO | Director | — | $29.46 | — | $0 | 1 | 2015-06-25 |
Recent Filings · Page 5 of 7
65 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-02-04 | CELGENE CORP /DE/ (CELGZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-01-02 | CELGENE CORP /DE/ (CELGZ) Delisted | Mixed | +4,061 | -$1.49M | EDGAR |
| 2014-12-23 | CELGENE CORP /DE/ (CELGZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-11-14 | CELGENE CORP /DE/ (CELGZ) Delisted | Mixed | −7,346 | -$3.17M | EDGAR |
| 2014-11-12 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | +10,252 | $13.5K | EDGAR |
| 2014-10-29 | CELGENE CORP /DE/ (CELGZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-08-05 | CELGENE CORP /DE/ (CELGZ) Delisted | Mixed | +7,346 | -$2.12M | EDGAR |
| 2014-07-29 | CELGENE CORP /DE/ (CELGZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-03-05 | CELGENE CORP /DE/ (CELGZ) Delisted | Sell (S) | −2,408 | -$383.0K | EDGAR |
| 2014-02-19 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | +20,000 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.